150 related articles for article (PubMed ID: 24135441)
1. Treatment satisfaction in renal transplant patients taking tacrolimus once daily.
van Boekel GA; Kerkhofs CH; Hilbrands LB
Clin Ther; 2013 Nov; 35(11):1821-9.e1. PubMed ID: 24135441
[TBL] [Abstract][Full Text] [Related]
2. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring.
Kuypers DR; Peeters PC; Sennesael JJ; Kianda MN; Vrijens B; Kristanto P; Dobbels F; Vanrenterghem Y; Kanaan N;
Transplantation; 2013 Jan; 95(2):333-40. PubMed ID: 23263559
[TBL] [Abstract][Full Text] [Related]
3. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.
Hatakeyama S; Fujita T; Yoneyama T; Yoneyama T; Koie T; Hashimoto Y; Saitoh H; Funyu T; Narumi S; Ohyama C
Transplant Proc; 2012 Jan; 44(1):121-3. PubMed ID: 22310594
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
Nakamura Y; Hama K; Katayama H; Soga A; Toraishi T; Yokoyama T; Kihara Y; Jojima Y; Konno O; Iwamoto H; Takeuchi H; Hirano T; Shimazu M
Transplant Proc; 2012 Jan; 44(1):124-7. PubMed ID: 22310595
[TBL] [Abstract][Full Text] [Related]
5. Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation.
Calia R; Lai C; Aceto P; Luciani M; Romagnoli J; Lai S; Gargiulo A; Citterio F
Transplant Proc; 2011 May; 43(4):1020-3. PubMed ID: 21620041
[TBL] [Abstract][Full Text] [Related]
6. Improvement of medication adherence with simplified once-daily immunosuppressive regimen in stable kidney transplant recipients: A prospective cohort study.
Oh CK; Bang JB; Kim SJ; Huh KH; Kim SJ; Jeon JS; Han SY; Cho HR; Kwon YJ; Lee SH; Kim YS
Asian J Surg; 2020 Jun; 43(6):660-667. PubMed ID: 31353239
[TBL] [Abstract][Full Text] [Related]
7. An observational study evaluating tacrolimus dose, exposure, and medication adherence after conversion from twice- to once-daily tacrolimus in liver and kidney transplant recipients.
Bäckman L; Persson CA
Ann Transplant; 2014 Mar; 19():138-44. PubMed ID: 24637379
[TBL] [Abstract][Full Text] [Related]
8. Impact of conversion to a once daily tacrolimus-based regimen in kidney transplant recipients with gastrointestinal complications.
Veroux M; Grosso G; Ekser B; Corona D; Giaquinta A; Veroux P
Transplantation; 2012 May; 93(9):895-9. PubMed ID: 22298033
[TBL] [Abstract][Full Text] [Related]
9. Increased medication compliance of liver transplant patients switched from a twice-daily to a once-daily tacrolimus-based immunosuppressive regimen.
Eberlin M; Otto G; Krämer I
Transplant Proc; 2013; 45(6):2314-20. PubMed ID: 23726723
[TBL] [Abstract][Full Text] [Related]
10. Successful conversion from twice-daily to once-daily tacrolimus in liver transplantation: observational multicenter study.
Dopazo C; Rodriguez R; Llado L; Calatayud D; Castells L; Ramos E; Molina V; García R; Fabregat J; Charco R
Clin Transplant; 2012; 26(1):E32-7. PubMed ID: 21958123
[TBL] [Abstract][Full Text] [Related]
11. Increased adherence after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation: a pre-experimental study.
Doesch AO; Mueller S; Konstandin M; Celik S; Erbel C; Kristen A; Frankenstein L; Koch A; Dengler TJ; Ehlermann P; Zugck C; De Geest S; Katus HA
Transplant Proc; 2010 Dec; 42(10):4238-42. PubMed ID: 21168673
[TBL] [Abstract][Full Text] [Related]
12. Comparison of pharmacokinetics and pathology for low-dose tacrolimus once-daily and twice-daily in living kidney transplantation: prospective trial in once-daily versus twice-daily tacrolimus.
Tsuchiya T; Ishida H; Tanabe T; Shimizu T; Honda K; Omoto K; Tanabe K
Transplantation; 2013 Jul; 96(2):198-204. PubMed ID: 23792649
[TBL] [Abstract][Full Text] [Related]
13. Significant reduction of Tacrolimus trough level after conversion from twice daily Prograf to once daily Advagraf in Chinese renal transplant recipients with or without concomitant diltiazem treatment.
Ma MK; Kwan LP; Mok MM; Yap DY; Tang CS; Chan TM
Ren Fail; 2013 Aug; 35(7):942-5. PubMed ID: 23815459
[TBL] [Abstract][Full Text] [Related]
14. First clinical experience with the new once-daily formulation of tacrolimus.
First MR
Ther Drug Monit; 2008 Apr; 30(2):159-66. PubMed ID: 18367975
[TBL] [Abstract][Full Text] [Related]
15. Early conversion from twice-daily tacrolimus to once-daily extended formulation in renal transplant patients before hospital discharge.
Jannot M; Masson I; Alamartine E; Mariat C
Ann Transplant; 2014 Jul; 19():320-4. PubMed ID: 24999809
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of once-daily modified-release tacrolimus in kidney transplant recipients: interim analysis of multicenter postmarketing surveillance in Japan.
Takahashi K; Abe R; Usuki S; So M
Transplant Proc; 2014; 46(2):406-10. PubMed ID: 24655975
[TBL] [Abstract][Full Text] [Related]
17. Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation.
Doesch AO; Mueller S; Akyol C; Erbel C; Frankenstein L; Ruhparwar A; Ehlermann P; Dengler TJ; Katus HA
Drug Des Devel Ther; 2013; 7():1253-8. PubMed ID: 24174870
[TBL] [Abstract][Full Text] [Related]
18. Impact of the conversion of the immunosuppressive regimen from prograf to advagraf or to sirolimus in long-term stable liver transplant recipients: indications, safety, and outcome.
Perrakis A; Schwarz K; Yedibela S; Croner RS; Hohenberger W; Müller V
Transplant Proc; 2011 Dec; 43(10):3702-7. PubMed ID: 22172830
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen.
Meçule A; Tinti F; Poli L; Bachetoni A; Umbro I; Nofroni I; Lai Q; Pretagostini R; Berloco PB; Mitterhofer AP
Transplant Proc; 2011 May; 43(4):1024-7. PubMed ID: 21620042
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the economic implications of non-adherence and antibody-mediated rejection in renal transplant recipients: the role of once-daily tacrolimus in the UK.
Muduma G; Odeyemi I; Pollock RF
J Med Econ; 2015; 18(12):1050-9. PubMed ID: 26201252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
